| 000 | 01741 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516203343.0 | ||
| 264 | 0 | _c20140818 | |
| 008 | 201408s 0 0 eng d | ||
| 022 | _a1097-6833 | ||
| 024 | 7 |
_a10.1016/j.jpeds.2014.02.025 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBaxter, Roger | |
| 245 | 0 | 0 |
_aAntibody persistence and booster response of a quadrivalent meningococcal conjugate vaccine in adolescents. _h[electronic resource] |
| 260 |
_bThe Journal of pediatrics _cJun 2014 |
||
| 300 |
_a1409-15.e4 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAntibodies, Bacterial _xblood |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunization, Secondary _xmethods |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMeningitis, Meningococcal _ximmunology |
| 650 | 0 | 4 |
_aMeningococcal Infections _ximmunology |
| 650 | 0 | 4 |
_aMeningococcal Vaccines _xadministration & dosage |
| 650 | 0 | 4 |
_aNeisseria meningitidis _ximmunology |
| 650 | 0 | 4 | _aPatient Safety |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVaccination _xmethods |
| 650 | 0 | 4 |
_aVaccines, Conjugate _xadministration & dosage |
| 700 | 1 | _aReisinger, Keith | |
| 700 | 1 | _aBlock, Stanley L | |
| 700 | 1 | _aIzu, Allen | |
| 700 | 1 | _aOdrljin, Tatjana | |
| 700 | 1 | _aDull, Peter | |
| 773 | 0 |
_tThe Journal of pediatrics _gvol. 164 _gno. 6 _gp. 1409-15.e4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jpeds.2014.02.025 _zAvailable from publisher's website |
| 999 |
_c23665374 _d23665374 |
||